WO2014109426A1 - Cosmetic composition comprising bacteriochlorophyll-containing microbial cell piece as active ingredient - Google Patents

Cosmetic composition comprising bacteriochlorophyll-containing microbial cell piece as active ingredient Download PDF

Info

Publication number
WO2014109426A1
WO2014109426A1 PCT/KR2013/000331 KR2013000331W WO2014109426A1 WO 2014109426 A1 WO2014109426 A1 WO 2014109426A1 KR 2013000331 W KR2013000331 W KR 2013000331W WO 2014109426 A1 WO2014109426 A1 WO 2014109426A1
Authority
WO
WIPO (PCT)
Prior art keywords
bacteriochlorophyll
cells
cosmetic composition
skin
photosynthetic
Prior art date
Application number
PCT/KR2013/000331
Other languages
French (fr)
Korean (ko)
Inventor
임태빈
조경숙
권덕수
조정섭
Original Assignee
주식회사 두산에코비즈넷
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 두산에코비즈넷 filed Critical 주식회사 두산에코비즈넷
Publication of WO2014109426A1 publication Critical patent/WO2014109426A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/82Preparation or application process involves sonication or ultrasonication

Definitions

  • the present invention relates to a cosmetic composition
  • a cosmetic composition comprising a bacteriochlorophyll-containing cell lysate as an active ingredient, and more particularly, to alleviate skin irritation including a bacteriochlorophyll-containing cell lysate obtained from Rhodobacter sphaeroides as an active ingredient. It relates to a cosmetic composition for moisturizing or skin.
  • Photosynthetic bacteria are independent nutrients and largely classified into green bacteria and red bacteria, and are widely distributed in rivers, lakes, and oceans. Photosynthetic bacteria play a major role in the circulation of carbon, nitrogen, and sulfur on the planet, and contribute greatly to the production of food and energy, to solving various environmental deterioration and pollution problems.
  • photosynthetic bacteria are evaluated as excellent nutrients with high nutritional value, and are superior to yeast or chlorella as food for chlorella, daphnia and early flora and fauna.
  • various bioactive components such as amino acids, vitamins, carotenoids, and bacteriochlorophyll in photosynthetic bacteria can be expected to nourish the skin and make the skin healthy.
  • the cosmetics market in Korea is ranked 10th in the world and is regarded as an important market leading the trend of the global cosmetics market. Domestic cosmetics sales amount to W7trn and still show high growth.
  • fermented cosmetics using microorganisms have grown to the largest cosmetic group after herbal cosmetics.
  • SKII products which have been selling high in Korea and overseas markets, have achieved great success by emphasizing yeast-derived “Pyterra”.
  • LG H & H's “Hu”, “Beautiful” and AMOREPACIFIC's “Hyosia” have fermentation technology as their main technology.
  • the market size of fermented cosmetics is estimated to be close to about 1 trillion won, and most of them use lactic acid bacteria or yeast that are not harmful to humans, and thus, there are many limitations in expanding the variety of products and brands.
  • the exploration of skin physiological activity of cell components or culture medium of photosynthetic bacteria can be said to be an important research theme that can further expand the field of fermented cosmetics limited to lactic acid bacteria and yeast.
  • Korean Patent Publication No. 10-2012-0098334 (published date 2012. 09. 05) includes duck oil, EM fermentation broth (fermentation solution of photosynthetic bacteria) and pozzo eggs to promote skin metabolism, moisturizing effect, and enhance cleansing power.
  • a functional cosmetic soap composition is characterized by having an effect, an anti-aging effect of the skin by an antioxidant effect, an antibacterial effect and an environmental purification effect.
  • the present invention as a photosynthetic bacterium, is intended to develop a cosmetic composition having a skin stimulating effect and skin moisturizing effect by using a cell lysate of Rhodobacter sphaeroides containing bacteriochlorophyll.
  • the present invention comprises the steps of culturing Rhodobacter sphaeroides containing bacteriochlorophyll (bacteriochlorophyll); after the culture, removing the culture medium and recovering the cells; Crushing the recovered cells; After crushing the cells, adding an extraction solvent and centrifuging; After centrifugation, recovering the supernatant; provides a cosmetic composition for alleviating skin irritation comprising a bacteriochlorophyll-containing extract prepared from the process as an active ingredient.
  • bacteriochlorophyll bacteriochlorophyll
  • the step of culturing Rhodobacter sphaeroides containing bacteriochlorophyll (bacteriochlorophyll); After the incubation, removing the culture solution and recovering the cells; Crushing the recovered cells; After crushing the cells, adding an extraction solvent and centrifuging; After centrifugation, recovering the supernatant; provides a moisturizing cosmetic composition comprising a bacteriochlorophyll-containing extract prepared from the process as an active ingredient.
  • This step is a step of culturing Rhodobacter sphaeroides containing bacteriochlorophyll (bacteriochlorophyll).
  • Rhodobacter sphaeroides belonging to the non-sulfur bacterium among photosynthetic bacteria are used, because it was confirmed that the bacteriochlorophyll was contained as a result of the experiment of the present invention.
  • Rhodobacter spheroides are rod-shaped or spherical with a width of 0.5-1.2 ⁇ m and a length of 2-2.5 ⁇ m. In the absence of oxygen, carbon assimilation can be done using light like plants, and in the absence of oxygen, oxygen and organic matter can be used to grow.
  • bacteriochlorophyll is an assimilation pigment of the photosynthetic bacteria, chlorophyll contained in the red bacteria such as red staphylococcus bacterium, red staphylococcus bacterium is called bacteriobiridine.
  • chlorophyll contained in the red bacteria such as red staphylococcus bacterium, red staphylococcus bacterium is called bacteriobiridine.
  • the structure is a have one of the four blood rolhaek common green chlorophyll-a of the plant (C 55 H 72 MgN 4 O 5) reduced form (C 55 H 74 MgN 4 O 5).
  • Rhodobacter sphaeroides containing bacteriochlorophyll having the same characteristics as described above are used.
  • the culture method may use a culture method well known in the art for photosynthetic bacteria. Since the present invention uses the extract obtained from the lysate of the cells, the culturing is better if the method can maximize the yield of the cells.
  • This step is to remove the culture medium and recover the cells after the culture.
  • the culture solution can be removed from the cells by a variety of methods, for example, can be removed after separation from the cells by centrifugation.
  • This step is to crush the cells recovered above. Since the present invention uses an extract derived from the lysate of the cells, the cells should be crushed. Crushing the cells is a variety of physical and chemical methods, preferably by applying an ultrasonic wave to the cells.
  • This step is a step of centrifugation after the cell disruption, the extraction solvent is added.
  • the extraction solvent is added to the cell lysate and centrifuged.
  • the useful substance is dissolved in the extraction solvent and extracted.
  • the extraction solvent is preferably used any one selected from water, ethanol aqueous solution, aqueous methanol solution, ethyl acetate, chloroform and hexane or a mixture thereof It is good.
  • This step is to recover the supernatant after the centrifugation.
  • This step is a process of separating the supernatant containing the useful component extracted through the extraction solvent.
  • the supernatant of this step contains bacteriochlorophyll as a useful component.
  • a cosmetic composition for skin irritation relief or skin moisturizing using the bacteriochlorophyll-containing extract prepared through the above steps as an active ingredient is prepared.
  • the cosmetic composition according to the present invention may contain, in addition to the above-mentioned extracts, other ingredients that can give a synergistic effect to the main effect, preferably within the range of not impairing the main effect of the present invention. It may also contain auxiliaries commonly used in the cosmetic field such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active agents, preservatives, antioxidants, solvents, fragrances, fillers, blockers, pigments, odorants and dyes. The amounts of these various adjuvants are amounts commonly used in the art, such as 0.0001 to 30% by weight relative to the total weight of the composition.
  • the formulation of the cosmetic composition of the present invention is not limited to a specific kind, for example, made up of a lotion, gel, water-soluble liquid, cream, essence, oil-in-water (O / W) type and water-in-oil (W / O) type Basic cosmetic formulations; It may be any one selected from oil-in-water and water-in-oil makeup base, foundation formulation.
  • the cosmetic composition of the present invention exhibits an excellent skin irritation alleviating effect and a skin moisturizing effect.
  • Rhodobacter sproidoids Rhodobacter sphaeroides
  • HaCaT skin keratinocyte line
  • Rhodobacter sproidoids Rhodobacter sphaeroides
  • HS68 skin dermal cell line
  • Rhodobacter spheroid death ( Rhodobacter sphaeroides ) According to the fractional concentration of DS-EBN-BL6, it shows the toxicity and proliferative effect of melanin forming cell line (B16F10; Melanocyte).
  • TNF- ⁇ shows the expression level of TNF- ⁇ according to the concentration of Rhodobacter sphaeroides DS-EBN-BL6 water extraction fraction.
  • Figure 6 shows the ability to inhibit the growth of keratinocytes (HaCaT; Keratinocyte) according to the concentration of bacteriochlorophyll (Bacteriochlorophyll), Astaxanthin (Astaxathin), Xanthophyll, Aminolevulinic acid (ALA).
  • Figure 7 shows the amount of TNF-a expression according to the concentration of bacteriochlorophyll (Bacteriochlorophyll), astaxanthin (Astaxathin), Xanthophyll, aminodebulic acid (ALA).
  • Figure 8 shows the results of artificial skin irritation of Rhodobacter sphaeroides DS-EBN-BL6 water extract fractions.
  • Rhodobacter capsulatus Rhodobacter sphaeroides
  • Rhodobacter azotoformans photosynthetic microbial strains isolated from our soil, river and wastewater sludge.
  • Rhodopseudomonas palustris ATCC 17001 Kelvan Ja Yong, Soo Kyung Lee, Myung Kyu Lee (2003), Phototropic Bacteria Producing technic development, Using agriculture and lomestic animals' waste.
  • the photosynthetic microorganisms were inoculated in the medium, and these were incubated for 48 hours at 150 rpm at a light source of 30 lux or more and a temperature of 30 ° C. using a shake incubator.
  • Bacteriochlorophyll analysis was performed according to the method described in Clayton, R. K. 1966. Spectroscopic analysis of bacteriochlorophylls in vitro and in vivo.Photochem.Photobiol.
  • the photosynthetic microorganism lysate was centrifuged at 12,000 rpm for 10 minutes (Supra 25K, KOREA), and the supernatant was collected.
  • Rhodobacter sphaeroides In the case of DS-EBN-BL6, the components of the bacteriochlorophyll were not the highest compared to other strains, but when converted based on the number of viable cells, it was found to contain the most content of all components.
  • Rhodobacter sphaeroides having excellent production capacity of bacteriochlorophyll Rhodobacter sphaeroides ) DS-EBN-BL6 was selected as the experimental strain and the skin cells and the improvement effect were verified below.
  • Rhodobacter Spiroides Rhodobacter sphaeroides ) DS-EBN-BL6 was deposited on August 9, 2010 with the Korea Research Institute of Bioscience and Biotechnology. KCTC11738BP was given.
  • MTT assay was performed to investigate the effects of photosynthetic microorganisms on skin cell growth.
  • Fibroblast, HaCaT, and B16F10 cells at a concentration of 7 ⁇ 10 3 were inoculated in 96 well plates and incubated for 24 hours, and then photosynthetic microbial lysates were treated in medium to further culture for 24 hours.
  • the group treated with the photosynthetic microbial culture medium and the culture supernatant from which the cells were removed were used as a control group and compared with the results of the experimental group samples.
  • TNF- ⁇ is a 'tumor necrosis factor' that signals tumor cells to kill themselves, inhibits intracellular replication of viruses, stimulates macrophages, and promotes inflammatory responses. are signaling molecules that are widely involved in the innate immune response.
  • TNF- ⁇ assay HaCaT cells were used to irradiate UV at 312 nm at 12.5 mJ, and then treated each fraction, incubated for 24 hours, and measured TNF- ⁇ secreted into the medium. The recovered medium was measured for absorbance at 450 nm using a microplate reader (Perkin Elmer, USA) using the TNF- ⁇ kit (invitrogen, # KHC3012).
  • bacteriochlorophyll was most excellent in virulence expression of HaCaT cells, and astaxanthin corresponding to xanthophylls among carotenoid pigments was excellent.
  • astaxanthin and bacteriochlorophyll were inhibited at the lowest concentration, as shown in FIG.
  • liposomes including photosynthetic bacterial fractions were prepared to check their stability.
  • hydrogenated purified soy lecithin was used to eliminate unsaturation.
  • Phospholipid general composition of the purified soy lecithin was shown in Table 1 below.
  • Liposomes of a certain size were then prepared by hydration and sonication at 60 ° C. above the phase transition temperature of the lipid.
  • Cosmetic formulations were developed using photosynthetic bacterial fractions. To the cream base of the following Table 4, the photosynthetic microbial culture lysate of the present invention was added to 10% to complete the formulation and proceed with the clinical experiment.
  • test group of the photosynthetic microbial fraction product prepared above and the control group other than the control group were commissioned to the PNK (P & K) Skin Clinical Research Center, and the "human efficacy evaluation for alleviation of itching caused by dry skin” was conducted according to the standard test method (SOP). It was.
  • Compliance with clinical product use was calculated as a percentage of the number of uses used over the course of the trial.
  • the total compliance of the 43 who completed the test was 95.7%, with a maximum compliance of 100% and a minimum compliance of 81.5%. Since no subjects showed less than 80% compliance in this trial, all 43 subject data were used for outcome analysis. Three of the 46 patients who participated in this trial were eliminated due to follow-up failure, and a total of 43 completed the trial.
  • the dropout information was as follows (Table 4).
  • the clinical trial results of the cream base product containing 10% photosynthetic microbial fraction and the cream base product to which the photosynthetic microbial fraction was not added were as shown in FIGS. 10 to 14.
  • the skin moisture content was increased by 15.25% after 2 weeks and 28.26% after 4 weeks of use compared to the change rate of the control product.
  • As for the epidermal moisture evaporation rate it was found to increase 9.42% after 2 weeks and 16.59% after 4 weeks of use, compared to the improvement rate of the control product.
  • the change in skin temperature was found to increase 0.14% after two weeks of use and 0.57% after four weeks of use, compared to the rate of improvement of the control product.
  • the SCORAD index increased by 1.39% after 2 weeks of use and 0.07% after 4 weeks of use, compared to the rate of change of the control product.
  • the cream base product containing photosynthetic microorganisms improved skin dryness as compared to the product containing no photosynthetic microorganisms.
  • the difference with the control product is not a large phenomenon due to the fact that the cream base formulation has some effect on skin improvement.

Abstract

The present invention relates to a cosmetic composition for relieving skin irritation or moisturizing the skin, including, as an active ingredient, a bacteriochlorophyll-containing microbial cell extract acquired from Rhodobacter sphaeroides, and displays excellent skin irritation relieving effects and skin moisturizing effects.

Description

박테리오클로로필 함유 균체 파쇄물을 유효성분으로 포함하는 화장료 조성물Cosmetic composition comprising bacteriochlorophyll-containing cell lysate as an active ingredient
본 발명은 박테리오클로로필 함유 균체 파쇄물을 유효성분으로 포함하는 화장료 조성물에 관한 것으로, 더욱 상세하게는 로도박터 스패로이드데스(Rhodobacter sphaeroides)로부터 수득한 박테리오클로로필 함유 균체 파쇄물을 유효성분으로 포함하는 피부 자극 완화용 또는 피부 보습용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition comprising a bacteriochlorophyll-containing cell lysate as an active ingredient, and more particularly, to alleviate skin irritation including a bacteriochlorophyll-containing cell lysate obtained from Rhodobacter sphaeroides as an active ingredient. It relates to a cosmetic composition for moisturizing or skin.
광합성 세균은 독립영양미생물로서 녹색세균(Green bacteria)과 홍색세균(Purple bacteria)로 크게 구별되며, 하천이나 호수, 해양 등에 널리 분포한다. 광합성 세균은 지구상의 탄소, 질소, 유황의 순환에 큰 역할을 수행하고, 식량과 에너지의 생산, 각종 환경 악화의 해결과 공해문제의 해결에 크게 기여하고 있다.  Photosynthetic bacteria are independent nutrients and largely classified into green bacteria and red bacteria, and are widely distributed in rivers, lakes, and oceans. Photosynthetic bacteria play a major role in the circulation of carbon, nitrogen, and sulfur on the planet, and contribute greatly to the production of food and energy, to solving various environmental deterioration and pollution problems.
또한, 광합성 세균은 영양가치가 높은 훌륭한 영양소로 평가받고 있는데, 클로렐라, 물벼룩 및 초기 동식물에 대한 먹이로서 효모나 클로렐라에 비해 우수한 것으로 평가받고 있다. 특히, 광합성 세균 내 아미노산, 비타민, 카로테노이드류, 박테리오클로로필 등의 다양한 생리활성 성분은 피부에 영양을 공급해 피부를 건강하게 할 것으로 기대할 수 있다.  In addition, photosynthetic bacteria are evaluated as excellent nutrients with high nutritional value, and are superior to yeast or chlorella as food for chlorella, daphnia and early flora and fauna. In particular, various bioactive components such as amino acids, vitamins, carotenoids, and bacteriochlorophyll in photosynthetic bacteria can be expected to nourish the skin and make the skin healthy.
한국 화장품 시장 규모는 세계 약 10위의 규모를 가지며, 세계 화장품 시장의 트렌드를 선도하는 중요한 시장으로 평가받고 있다. 국내 화장품의 매출 규모는 약 7조 원에 이르고 있으며, 여전히 높은 성장률을 보이고 있다.  The cosmetics market in Korea is ranked 10th in the world and is regarded as an important market leading the trend of the global cosmetics market. Domestic cosmetics sales amount to W7trn and still show high growth.
2000년대 후반기부터 화장품 산업에 발효 미생물의 사용이 증가하면서 미생물을 이용한 발효 화장품은 한방 화장품 다음으로 큰 화장품 군으로 성장하고 있다. 한국 및 해외시장에서 높은 판매를 보이고 있는 SKII 제품은 효모 유래의 “피테라”라는 성분을 강조하여 큰 성공을 거두었다. 국내에서도 (주)엘지생활건강의 “후”, “수려한”, (주)아모레퍼시픽의 “효시아”등은 발효기술을 주요기술로 하고 있다. 발효화장품의 시장규모는 약 1조원에 가까운 것으로 추산되는데, 대부분은 인체 유해성이 없는 유산균이나 효모를 이용하는 것으로 제품 및 브랜드의 다양성을 넓히는 데는 많은 한계를 가진다.  As the use of fermented microorganisms has increased in the cosmetic industry since the late 2000s, fermented cosmetics using microorganisms have grown to the largest cosmetic group after herbal cosmetics. SKII products, which have been selling high in Korea and overseas markets, have achieved great success by emphasizing yeast-derived “Pyterra”. In Korea, LG H & H's “Hu”, “Beautiful” and AMOREPACIFIC's “Hyosia” have fermentation technology as their main technology. The market size of fermented cosmetics is estimated to be close to about 1 trillion won, and most of them use lactic acid bacteria or yeast that are not harmful to humans, and thus, there are many limitations in expanding the variety of products and brands.
따라서, 광합성 세균의 균체 성분 또는 배양액의 피부생리활성 탐색은 유산균, 효모에 한정되어 있는 발효 화장품의 분야를 더욱 확장시킬 수 있는 중요한 연구 테마라 할 수 있다.  Therefore, the exploration of skin physiological activity of cell components or culture medium of photosynthetic bacteria can be said to be an important research theme that can further expand the field of fermented cosmetics limited to lactic acid bacteria and yeast.
대한민국 특허공개번호 제10-2012-0098334호(공개일자 2012. 09. 05)에는, 오리유, EM 발효액(광합성 세균의 발효액) 및 포조란을 포함함으로써, 피부 신진대사 촉진, 보습 효과, 세정력 강화 효과, 항산화 효과에 의한 피부 노화예방 효과, 항균 효과 및 환경정화 효과를 가지는 특징이 있는 기능성 화장비누 조성물이 기재되어 있다.  Korean Patent Publication No. 10-2012-0098334 (published date 2012. 09. 05) includes duck oil, EM fermentation broth (fermentation solution of photosynthetic bacteria) and pozzo eggs to promote skin metabolism, moisturizing effect, and enhance cleansing power. A functional cosmetic soap composition is characterized by having an effect, an anti-aging effect of the skin by an antioxidant effect, an antibacterial effect and an environmental purification effect.
본 발명은 광합성 세균으로서, 박테리오클로로필(bacteriochlorophyll)을 함유하는 로도박터 스패로이드데스(Rhodobacter sphaeroides)의 균체 파쇄물을 이용하여 피부 자극 완화 및 피부 보습 효과가 있는 화장료 조성물을 개발하고자 한다. The present invention, as a photosynthetic bacterium, is intended to develop a cosmetic composition having a skin stimulating effect and skin moisturizing effect by using a cell lysate of Rhodobacter sphaeroides containing bacteriochlorophyll.
본 발명은 제1형태로, 박테리오클로로필(bacteriochlorophyll)을 함유하는 로도박터 스패로이드데스(Rhodobacter sphaeroides)를 배양하는 단계;상기 배양 후, 배양액을 제거하고 균체를 회수하는 단계; 상기에서 회수한 균체를 파쇄하는 단계; 상기 균체 파쇄 후, 추출 용매를 가하고 원심분리하는 단계; 상기 원심분리 후, 상등액을 회수하는 단계;를 포함하는 과정으로부터 제조된 박테리오클로로필 함유 추출액을 유효성분으로 포함하는 것을 특징으로 하는 피부 자극 완화용 화장료 조성물을 제공한다. The present invention comprises the steps of culturing Rhodobacter sphaeroides containing bacteriochlorophyll (bacteriochlorophyll); after the culture, removing the culture medium and recovering the cells; Crushing the recovered cells; After crushing the cells, adding an extraction solvent and centrifuging; After centrifugation, recovering the supernatant; provides a cosmetic composition for alleviating skin irritation comprising a bacteriochlorophyll-containing extract prepared from the process as an active ingredient.
또한, 본 발명은 제2형태로, 박테리오클로로필(bacteriochlorophyll)을 함유하는 로도박터 스패로이드데스(Rhodobacter sphaeroides)를 배양하는 단계; 상기 배양 후, 배양액을 제거하고 균체를 회수하는 단계; 상기에서 회수한 균체를 파쇄하는 단계; 상기 균체 파쇄 후, 추출 용매를 가하고 원심분리하는 단계; 상기 원심분리 후, 상등액을 회수하는 단계;를 포함하는 과정으로부터 제조된 박테리오클로로필 함유 추출액을 유효성분으로 포함하는 것을 특징으로 하는 피부 보습용 화장료 조성물을 제공한다. In another aspect, the present invention, the step of culturing Rhodobacter sphaeroides containing bacteriochlorophyll (bacteriochlorophyll); After the incubation, removing the culture solution and recovering the cells; Crushing the recovered cells; After crushing the cells, adding an extraction solvent and centrifuging; After centrifugation, recovering the supernatant; provides a moisturizing cosmetic composition comprising a bacteriochlorophyll-containing extract prepared from the process as an active ingredient.
이하, 본 발명의 제1형태 및 제2형태에 대해 각 단계별로 상세히 설명하고자 한다. Hereinafter, the first aspect and the second aspect of the present invention will be described in detail for each step.
<배양 단계: 박테리오클로로필을 함유하는 로도박터 스패로이드데스의 배양><Cultivation Step: Culture of Rhodobacter Spoidoids Containing Bacteriochlorophyll
본 단계는 박테리오클로로필(bacteriochlorophyll)을 함유하는 로도박터 스패로이드데스(Rhodobacter sphaeroides)를 배양하는 단계이다. This step is a step of culturing Rhodobacter sphaeroides containing bacteriochlorophyll (bacteriochlorophyll).
본 발명에서는 광합성 세균 중 홍색비유황세균에 속하는 로도박터 스패로이드데스(Rhodobacter sphaeroides)를 이용하는데, 본 발명의 실험 결과 박테리오클로로필을 많이 함유하고 있는 것으로 확인되었기 때문이다. 로도박터 스패로이드데스는 폭이 0.5∼1.2 ㎛, 길이 2∼2.5 ㎛의 막대 형태 또는 구형이다. 산소가 없는 조건에서는 식물처럼 빛을 이용하여 탄소동화작용을 할 수 있으며, 빛이 없는 경우 산소와 유기물을 이용하여 생육할 수 있는 특징을 갖는다. In the present invention, Rhodobacter sphaeroides belonging to the non-sulfur bacterium among photosynthetic bacteria are used, because it was confirmed that the bacteriochlorophyll was contained as a result of the experiment of the present invention. Rhodobacter spheroides are rod-shaped or spherical with a width of 0.5-1.2 μm and a length of 2-2.5 μm. In the absence of oxygen, carbon assimilation can be done using light like plants, and in the absence of oxygen, oxygen and organic matter can be used to grow.
한편, 박테리오클로로필(bacteriochlorophyll)은 광합성 세균이 지닌 동화색소로, 홍색황세균, 홍색무황세균 등의 홍색세균에 들어 있는 클로로필은 박테리오비리딘이라고 한다. 박테리오클로로필에는 a, b 등 몇 가지 색소가 존재하는데, 구조의 명확한 주색소를 박테리오클로로필 a라고 부르는 경우도 있다. 그 구조는 일반 녹색식물의 클로로필 a(C55H72MgN4O5)의 피롤핵 4개 중에서 1개가 환원된 형태이다(C55H74MgN4O5). 알코올 용액에서는 357.5 nm와 770 nm에 주요 흡수 극대가 있는데, 세포 내에서는 단백질과 결합되어 있고, 380 nm와 890, 870, 850, 800 nm에서 흡수극대를 나타낸다. 이 중에서 890 nm의 빛 부분이 광합성에 이용되며, 그 부분에서 형광을 낸다.On the other hand, bacteriochlorophyll (bacteriochlorophyll) is an assimilation pigment of the photosynthetic bacteria, chlorophyll contained in the red bacteria such as red staphylococcus bacterium, red staphylococcus bacterium is called bacteriobiridine. There are several pigments such as a and b in the bacteriochlorophyll, and the clear main pigment of the structure is sometimes called the bacteriochlorophyll a. The structure is a have one of the four blood rolhaek common green chlorophyll-a of the plant (C 55 H 72 MgN 4 O 5) reduced form (C 55 H 74 MgN 4 O 5). In alcoholic solutions, there are major absorption peaks at 357.5 nm and 770 nm, which are bound to proteins in cells and show absorption peaks at 380 nm and 890, 870, 850, and 800 nm. Of these, a light portion of 890 nm is used for photosynthesis, and fluoresces there.
본 단계에서는 이상에서 살펴본 것과 같은 특징이 있는 박테리오클로로필(bacteriochlorophyll)을 함유하는 로도박터 스패로이드데스(Rhodobacter sphaeroides)를 이용한다. 배양 방법은 광합성 세균에 대한 당업계에 널리 알려진 배양 방법을 이용할 수 있다. 본 발명은 균체의 파쇄물로부터 수득한 추출물을 이용하기 때문에, 배양은 균체의 생산량을 극대화할 수 있는 방법이라면 더욱 좋다. In this step, Rhodobacter sphaeroides containing bacteriochlorophyll having the same characteristics as described above are used. The culture method may use a culture method well known in the art for photosynthetic bacteria. Since the present invention uses the extract obtained from the lysate of the cells, the culturing is better if the method can maximize the yield of the cells.
<균체 회수 단계; 배양액을 제거하고 균체를 회수>Cell recovery step; Remove the culture solution and collect the cells>
본 단계는 상기 배양 후, 배양액을 제거하고 균체를 회수하는 단계이다. 배양액은 다양한 방법을 통해 균체로부터 분리하여 제거할 수 있는데, 일 예로는 원심분리를 통해 균체와 분리한 후, 제거할 수 있다. This step is to remove the culture medium and recover the cells after the culture. The culture solution can be removed from the cells by a variety of methods, for example, can be removed after separation from the cells by centrifugation.
<균체 파쇄 단계: 회수한 균체의 파쇄><Cutting of Cells: Crushing of Recovered Cells>
본 단계는 상기에서 회수한 균체를 파쇄하는 단계이다. 본 발명은 균체의 파쇄물로부터 유래한 추출물을 이용하기 때문에 균체를 파쇄해야 한다. 균체의 파쇄는 물리적, 화학적 방법의 다양한 것들이 있는데, 바람직하게는 균체에 초음파를 가하여 수행하는 것이 좋다. This step is to crush the cells recovered above. Since the present invention uses an extract derived from the lysate of the cells, the cells should be crushed. Crushing the cells is a variety of physical and chemical methods, preferably by applying an ultrasonic wave to the cells.
<원심분리 단계: 추출 용매를 가하고 원심분리><Centrifugation Step: Add Extraction Solvent and Centrifuge>
본 단계는 상기 균체 파쇄 후, 추출 용매를 가하고 원심분리하는 단계이다. 본 단계에서는 균체 파쇄물에 추출 용매를 가하고 원심분리하는 단계이다. 본 단계를 통해 유용물질이 추출 용매에 녹아 추출된다. 이때, 추출 용매의 종류에 따라 추출되는 유용성분의 종류 및 양이 변하게 되는데, 추출 용매는 바람직하게 물, 에탄올 수용액, 메탄올 수용액, 에틸 아세테이트, 클로로포름 및 헥산 중 선택되는 어느 하나 또는 이들을 혼합해서 사용하는 것이 좋다. This step is a step of centrifugation after the cell disruption, the extraction solvent is added. In this step, the extraction solvent is added to the cell lysate and centrifuged. Through this step, the useful substance is dissolved in the extraction solvent and extracted. At this time, the kind and amount of useful components to be extracted are changed according to the type of the extraction solvent, the extraction solvent is preferably used any one selected from water, ethanol aqueous solution, aqueous methanol solution, ethyl acetate, chloroform and hexane or a mixture thereof It is good.
<상등액 회수 단계: 상등액을 회수하는 단계>Supernatant recovery step: recovering the supernatant
본 단계는 상기 원심분리 후, 상등액을 회수하는 단계이다. 본 단계는 추출 용매를 통해 추출된 유용성분 함유 상등액을 분리하는 과정이다. 본 단계의 상등액에는 유용성분으로 박테리오클로로필이 함유되어 있다.  This step is to recover the supernatant after the centrifugation. This step is a process of separating the supernatant containing the useful component extracted through the extraction solvent. The supernatant of this step contains bacteriochlorophyll as a useful component.
본 발명에서는 상기의 단계를 거쳐 제조된 박테리오클로로필 함유 추출액을 유효성분으로 하는 피부 자극 완화용 또는 피부 보습용 화장료 조성물을 제조한다.  In the present invention, a cosmetic composition for skin irritation relief or skin moisturizing using the bacteriochlorophyll-containing extract prepared through the above steps as an active ingredient is prepared.
본 발명에 따른 화장료 조성물은 상기의 추출물 외에 본 발명이 목적으로 하는 주 효과를 손상시키지 않는 범위 내에서 바람직하게는 주 효과에 상승효과를 줄 수 있는 다른 성분 등을 함유하는 것도 무방하다. 또한, 화장품 분야에서 통상적인 사용되는 보조제 예컨대 친수성 또는 친유성 겔화제, 친수성 또는 친유성 활성제, 보존제, 항산화제, 용매, 방향제, 충전제, 차단제, 안료, 흡취제 및 염료를 함유할 수 있다. 이들 다양한 보조제의 양은 당해 분야에서 통상적으로 사용되는 양이며, 예컨대 조성물 총중량에 대해 0.0001 내지 30중량%이다.  The cosmetic composition according to the present invention may contain, in addition to the above-mentioned extracts, other ingredients that can give a synergistic effect to the main effect, preferably within the range of not impairing the main effect of the present invention. It may also contain auxiliaries commonly used in the cosmetic field such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active agents, preservatives, antioxidants, solvents, fragrances, fillers, blockers, pigments, odorants and dyes. The amounts of these various adjuvants are amounts commonly used in the art, such as 0.0001 to 30% by weight relative to the total weight of the composition.
한편, 본 발명 화장료 조성물의 제형은 특정의 종류에 한정되는 것은 아니나, 일 예로 화장수, 젤, 수용성 리퀴드, 크림, 에센스, 수중유(O/W)형 및 유중수(W/O)형으로 이루어진 기초화장료 제형과; 수중유형 및 유중수형 메이크업베이스, 파운데이션 제형 중에서 선택되는 어느 하나일 수 있다.  On the other hand, the formulation of the cosmetic composition of the present invention is not limited to a specific kind, for example, made up of a lotion, gel, water-soluble liquid, cream, essence, oil-in-water (O / W) type and water-in-oil (W / O) type Basic cosmetic formulations; It may be any one selected from oil-in-water and water-in-oil makeup base, foundation formulation.
본 발명의 화장료 조성물은 우수한 피부 자극 완화 효과와 피부 보습 효과를 발휘한다.  The cosmetic composition of the present invention exhibits an excellent skin irritation alleviating effect and a skin moisturizing effect.
도 1은 광합성 미생물 균주별 박테리오클로로필(bacteriochlorophyll)의 분석 결과이다. 이때, 배양은 모두 호기명 조건에서 수행하였다.  1 is a result of analysis of bacteriochlorophyll for photosynthetic microbial strains. At this time, the culture was all carried out under aerobic conditions.
도 2는 로도박터 스패로이드데스(Rhodobacter sphaeroides) DS-EBN-BL6의 분획별 농도에 따른, 피부 각질 세포주(HaCaT; Keratinocyte)의 독성 및 증식 효과를 보여준다.  2 is Rhodobacter sproidoids (Rhodobacter sphaeroides) According to the fractional concentration of DS-EBN-BL6, it shows the toxicity and proliferative effect of skin keratinocyte line (HaCaT; Keratinocyte).
도 3은 로도박터 스패로이드데스(Rhodobacter sphaeroides) DS-EBN-BL6의 분획별 농도에 따른, 피부 진피 세포주(HS68; Fibroblast)의 독성 및 증식 효과를 보여준다.  3 is Rhodobacter sproidoids (Rhodobacter sphaeroides) According to the fractional concentration of DS-EBN-BL6, it shows the toxic and proliferative effect of skin dermal cell line (HS68; Fibroblast).
도 4는 로도박터 스패로이드데스(Rhodobacter sphaeroides) DS-EBN-BL6의 분획별 농도에 따른, 멜라닌 형성 세포주(B16F10; Melanocyte)의 독성 및 증식 효과를 보여준다.  4 is Rhodobacter spheroid death (Rhodobacter sphaeroides) According to the fractional concentration of DS-EBN-BL6, it shows the toxicity and proliferative effect of melanin forming cell line (B16F10; Melanocyte).
도 5는 로도박터 스패로이드데스(Rhodobacter sphaeroides) DS-EBN-BL6 물 추출 분획물의 농도에 따른 TNF-α의 발현량을 보여준다.5 shows the expression level of TNF-α according to the concentration of Rhodobacter sphaeroides DS-EBN-BL6 water extraction fraction.
도 6은 박테리오클로로필(Bacteriochlorophyll), 아스타잔틴(Astaxathin), 잔토필(Xanthophyll), 아미노데불리닉 산(Aminolevulinic acid, ALA)의 농도에 따른 피부 각질 세포주(HaCaT; Keratinocyte) 성장 억제능을 보여준다. Figure 6 shows the ability to inhibit the growth of keratinocytes (HaCaT; Keratinocyte) according to the concentration of bacteriochlorophyll (Bacteriochlorophyll), Astaxanthin (Astaxathin), Xanthophyll, Aminolevulinic acid (ALA).
도 7은 박테리오클로로필(Bacteriochlorophyll), 아스타잔틴(Astaxathin), 잔토필(Xanthophyll), 아미노데불리닉 산(Aminolevulinic acid, ALA)의 농도에 따른 TNF-a 발현량을 보여준다. Figure 7 shows the amount of TNF-a expression according to the concentration of bacteriochlorophyll (Bacteriochlorophyll), astaxanthin (Astaxathin), Xanthophyll, aminodebulic acid (ALA).
도 8은 로도박터 스패로이드데스(Rhodobacter sphaeroides) DS-EBN-BL6 물 추출 분획물의 인공피부 자극 결과를 보여준다. Figure 8 shows the results of artificial skin irritation of Rhodobacter sphaeroides DS-EBN-BL6 water extract fractions.
도 9는 광합성 미생물 물 추출 분획물의 리포좀 제형 안정성 결과를 보여준다. 9 shows liposome formulation stability results of photosynthetic microbial water extract fractions.
도 10 내지 14는 광합성 미생물 함유 제품과 미함유 제품의 임상시험 결과를 보여준다. 10-14 show the results of clinical trials of photosynthetic microbial containing and non-containing products.
이하, 본 발명의 내용을 하기 실시예를 통해 더욱 상세히 설명하고자 한다. 다만, 본 발명의 권리범위가 하기 실시예에만 한정되는 것은 아니고, 그와 등가의 기술적 사상의 변형까지를 포함한다. Hereinafter, the content of the present invention will be described in more detail through the following examples. However, the scope of the present invention is not limited only to the following examples, but includes modifications of equivalent technical ideas.
[실시예 1: 여러가지 광합성 세균 내 박테리오클로로필의 함량 분석]Example 1 Analysis of the Content of Bacteriochlorophyll in Various Photosynthetic Bacteria
본 실시예에서는 여러가지 광합성 세균들의 균체 내 박테리오클로로필 함량을 분석하고자 하였다. 박테리오클로로필 분석에 사용된 균주는 당사 보유의 토양, 하천 그리고 폐수 슬러지로부터 분리한 광합성 미생물 균주인 Rhodobacter capsulatus, Rhodobacter sphaeroidesRhodobacter azotoformans이었다. 대조구로는 Rhodopseudomonas palustris ATCC 17001(구자용, 이수경, 이명규(2003). Phototropic Bacteria Producing technic development, Using agriculture and lomestic animals' waste.)를 사용하였으며, 아래와 같은 방법으로 배양한 후 분석하였다.In this example, the bacteriochlorophyll content in cells of various photosynthetic bacteria was analyzed. The strains used for bacteriochlorophyll analysis were Rhodobacter capsulatus, Rhodobacter sphaeroides and Rhodobacter azotoformans , photosynthetic microbial strains isolated from our soil, river and wastewater sludge. As a control, Rhodopseudomonas palustris ATCC 17001 (Koo Ja Yong, Soo Kyung Lee, Myung Kyu Lee (2003), Phototropic Bacteria Producing technic development, Using agriculture and lomestic animals' waste.) Was used.
배지 1리터당 K2HPO4 0.5g, KH2PO4 0.5g, DL-Malic acid 2.7g, Ammonium phosphate 0.8g, MSG 3.76g, Tryptone 1g, Yeast extract 2g 및 T.E 2.1ml 조성의 광합성 미생물용 기본 액체배지에 상기 광합성 미생물을 각각 접종하고, 이를 진탕 배양기를 이용하여 50룩스 이상의 광원 및 30℃의 온도에서 150 rpm으로 48시간 동안 배양하였다. 0.5 g of K 2 HPO 4, 0.5 g of KH 2 PO 4 , 2.7 g of DL-Malic acid, 0.8 g of Ammonium phosphate, 3.76 g of MSG, 1 g of Tryptone, 2 g of Yeast extract, and TE 2.1 ml The photosynthetic microorganisms were inoculated in the medium, and these were incubated for 48 hours at 150 rpm at a light source of 30 lux or more and a temperature of 30 ° C. using a shake incubator.
박테리오클로로필 분석은 클레이튼(Clayton, R. K. 1966. Spectroscopic analysis of bacteriochlorophylls in vitro and in vivo. Photochem. Photobiol. 5:669-677)의 논문에 기재된 방법에 준해 수행하고, 구체적인 과정은 하기와 같았다.  Bacteriochlorophyll analysis was performed according to the method described in Clayton, R. K. 1966. Spectroscopic analysis of bacteriochlorophylls in vitro and in vivo.Photochem.Photobiol.
① 각각의 광합성 미생물 배양액을 6,000 rpm에서 10분 간 원심분리한(Supra 25K, KOREA) 후 상등액을 제거하였다.  ① Each photosynthetic microbial culture was centrifuged at 6,000 rpm for 10 minutes (Supra 25K, KOREA) and the supernatant was removed.
② 상등액이 제거된 광합성 미생물 펠렛을 수거하여 Sonicator(VCX-750, USA)를 이용하여, 20 kHz 주파수, 25% 진폭으로 5초 작동 2초 정지 순으로 10분 간, 25 mm solid probe를 이용하여 세포를 파쇄하였다. ② Collect the photosynthetic microbial pellet from which the supernatant was removed, and use Sonicator (VCX-750, USA) for 20 minutes at 20 kHz frequency and 25% amplitude for 2 minutes and then stop for 10 minutes using 25 mm solid probe. Cells were disrupted.
③ 파쇄된 세포를 메틸 알코올:아세톤=7:2로 제조된 용매를 이용하여 빛을 차단한 채 30분 간 반응시켰다.  ③ The crushed cells were reacted for 30 minutes while blocking the light using a solvent prepared in methyl alcohol: acetone = 7: 2.
④ 반응이 완료된 광합성 미생물 파쇄체를 12,000 rpm에서 10분 간 원심분리(Supra 25K, KOREA) 후, 상등액을 수거하였다.  ④ After the reaction was completed, the photosynthetic microorganism lysate was centrifuged at 12,000 rpm for 10 minutes (Supra 25K, KOREA), and the supernatant was collected.
⑤ 수거된 상등액의 Optical Density Value(770 nm)를 측정하였다. ⑤ Optical Density Value (770 nm) of the collected supernatant was measured.
광합성 미생물 균주별 박테리오클로로필의 분석 결과는 도 1과 같았다. Rhodobacter sphaeroides DS-EBN-BL6의 경우, 박테리오클로로필의 성분이 타 균주에 비해 가장 높게 나타나지는 않았으나, 생균수(Viable Cell)를 기준으로 변환할 경우, 모든 성분의 함량을 가장 많이 함유하고 있는 것으로 나타났다.  Analysis of the bacteriochlorophyll for each photosynthetic microorganism strain was as shown in FIG. 1.Rhodobacter sphaeroidesIn the case of DS-EBN-BL6, the components of the bacteriochlorophyll were not the highest compared to other strains, but when converted based on the number of viable cells, it was found to contain the most content of all components.
이를 토대로 본 발명에서는 박테리오클로로필의 생산능이 우수한 로도박터 스패로이데스(Rhodobacter sphaeroides) DS-EBN-BL6를 실험균주로 선정하고, 피부세포 및 개선 효능 효과를 하기에서 검증하였다. 로도박터 스패로이데스(Rhodobacter sphaeroides) DS-EBN-BL6은 2010년 8월 9일자로 한국생명공학연구원에 기탁되었고, 기탁번호 KCTC11738BP를 부여받았다.  Based on this, in the present invention, Rhodobacter sphaeroides having excellent production capacity of bacteriochlorophyll (Rhodobacter sphaeroides) DS-EBN-BL6 was selected as the experimental strain and the skin cells and the improvement effect were verified below. Rhodobacter SpiroidesRhodobacter sphaeroides) DS-EBN-BL6 was deposited on August 9, 2010 with the Korea Research Institute of Bioscience and Biotechnology. KCTC11738BP was given.
[실시예 2: 선별된 광합성 미생물의 피부 개선 효과 확인(Example 2: Confirming the skin improvement effect of the selected photosynthetic microorganisms ( In vitroIn vitro )])]
피부 개선능 테스트에 앞서, 광합성 세균 균체의 분획을 얻기 위해 다양한 용매를 이용하여 시료를 준비하였으며, 방법은 아래와 같았다. Prior to the skin improvement test, samples were prepared using various solvents to obtain a fraction of photosynthetic bacterial cells, and the method was as follows.
① 물 추출, ② EtOH 추출, ③ 70% EtOH 추출, ④ MeOH 추출, ⑤ 70% MeOH 추출, ⑥ Hexane 추출, ⑦ Hexane:EtOH=3:1 추출, ⑧ Chloroform:MeOH=2:1 추출.  ① Water extraction, ② EtOH extraction, ③ 70% EtOH extraction, ④ MeOH extraction, ⑤ 70% MeOH extraction, ⑥ Hexane extraction, ⑦ Hexane: EtOH = 3: 1 extraction, ⑧ Chloroform: MeOH = 2: 1 extraction.
추출은 60℃에서 12시간 동안 서서히 교반하면서 진행하였다. 각 용매에서 12시간 동안 추출한 후 추출액을 여과하고, 진공 건조하여 추출물을 얻었다. 이후, 상기의 광합성 미생물 추출물을 DMSO(Dimethyl sulfoxide)에 용해하여 하기의 효능평가 실험을 진행하였다.  Extraction proceeded slowly at 12O &lt; 0 &gt; C for 12 hours. After extraction for 12 hours in each solvent, the extract was filtered and dried in vacuo to obtain an extract. Thereafter, the photosynthetic microbial extract was dissolved in DMSO (dimethyl sulfoxide), and the following efficacy evaluation experiment was conducted.
광합성 미생물이 피부 세포 성장에 미치는 영향을 알아보기 위해 MTT assay를 진행하였다. 7×103 농도의 피브로블라스트(Fibroblast), HaCaT, B16F10 세포를 96 웰 플레이트에 접종하여 24시간 동안 배양한 후, 광합성 미생물 파쇄체를 배지에 농도별로 처리하여 24시간 동안 추가 배양하였다. 이때, 광합성 미생물 배양 배지만 처리한 그룹과 균체가 제거된 배양 상등액을 대조군으로 사용하여 실험군 시료의 결과와 비교하였다.MTT assay was performed to investigate the effects of photosynthetic microorganisms on skin cell growth. Fibroblast, HaCaT, and B16F10 cells at a concentration of 7 × 10 3 were inoculated in 96 well plates and incubated for 24 hours, and then photosynthetic microbial lysates were treated in medium to further culture for 24 hours. At this time, the group treated with the photosynthetic microbial culture medium and the culture supernatant from which the cells were removed were used as a control group and compared with the results of the experimental group samples.
실험 결과, 도 2 내지 4에서 보는 바와 같이 헥산, 클로로포름 그리고 MeOH를 이용한 분획에서 농도 의존적 독성이 발현되었다. 하지만, 각 세포주의 특성상 성장 억제(HaCaT, B16F10)와 성장 증식(Fibroblast)의 양존성을 보유하는 것이 좋으며, 사용 용매의 안전성 등을 기준으로 봤을 때, 물을 이용한 분획이 가장 적합하리라 사료되었다. 즉, 물을 이용한 분획의 경우는 'R. sphaeroides DS-EBN-BL6의 배양을 위해 사용되는 배지'와 '분획을 위해 사용되는 균체가 없는 상등액'에 비해 각질 세포주와 멜라닌 형성 세포주에 대한 독성과 진피 세포주에 대한 성장 증식 효과를 갖기 때문에 효과적인 면에서도 우수한 것이다. As a result, as shown in Figures 2 to 4 concentration-dependent toxicity was expressed in the fraction using hexane, chloroform and MeOH. However, due to the characteristics of each cell line, it is good to have the compatibility of growth inhibition (HaCaT, B16F10) and growth proliferation (Fibroblast), and based on the safety of the solvent used, it is considered that the fraction using water is most suitable. In other words, the fractions using water were more toxic to keratinocytes and melanin-forming cell lines than 'medium used for culturing R. sphaeroides DS-EBN-BL6' and 'supernatant without cells used for fractionation'. It is excellent in terms of effectiveness because it has a growth proliferation effect on the dermal cell line.
한편, 항염증 활성을 측정하고자 하였는데, 항염증 활성은 대표적인 염증성 사이토카인(cytokine)인 TNF-α의 감소 효과를 측정하여 평가하였으며, 대조군으로는 덱사메타손(Dexamethason)을 사용하였다. TNF-α는 '종양괴사인자'로, 종양세포에 신호를 주어 자살하도록 만들거나, 그밖에 바이러스의 세포 내 복제를 저해하기도 하고, 대식세포를 자극하기도 하며, 염증반응을 촉진하는 등, 내재면역반응(innate immune response)에 폭넓게 관여하는 신호분자이다.  Meanwhile, the anti-inflammatory activity was measured. The anti-inflammatory activity was evaluated by measuring the reduction effect of TNF-α, which is a representative inflammatory cytokine, and dexamethasone was used as a control. TNF-α is a 'tumor necrosis factor' that signals tumor cells to kill themselves, inhibits intracellular replication of viruses, stimulates macrophages, and promotes inflammatory responses. are signaling molecules that are widely involved in the innate immune response.
실험을 위해 1×105 농도의 HaCaT 세포를 12 웰 플레이트에 접종하여 24시간 동안 배양한 후 TNF-α를 유도시키기 위한 의도로 UV 조사와 함께 시료를 배지에 농도별로 처리하여 24시간 동안 추가 배양하였다. 'UV를 처리하지 않은 경우', 'UV를 처리 후 덱사메타손을 1uM/ml 처리한 그룹'을 대조군으로 사용하여 시료의 결과와 비교하였다.For experiments, 1 × 10 5 concentrations of HaCaT cells were inoculated into 12 well plates and incubated for 24 hours, and then the samples were treated in different concentrations in the medium with UV irradiation for the purpose of inducing TNF-α and further cultured for 24 hours. It was. When not treated with UV, the group treated with dexamethasone treated with 1 μM / ml after UV was used as a control and compared with the results of the samples.
TNF-α 어세이의 경우, HaCaT 세포를 이용하여 312 nm에서 12.5 mJ로 UV를 조사한 후, 각 분획물을 처리하고, 24시간 동안 배양한 후, 배지로 분비되는 TNF-α를 측정하였다. 회수한 배지는 TNF-α 키트(invitrogen, #KHC3012)를 사용하여 마이크로플레이트 리더(Perkin Elmer, USA) 를 이용하여 450 nm에서 흡광도를 측정하였다. In the case of the TNF-α assay, HaCaT cells were used to irradiate UV at 312 nm at 12.5 mJ, and then treated each fraction, incubated for 24 hours, and measured TNF-α secreted into the medium. The recovered medium was measured for absorbance at 450 nm using a microplate reader (Perkin Elmer, USA) using the TNF-α kit (invitrogen, # KHC3012).
실험 결과, 광합성 미생물 물 분획물의 경우, 각질세포와 멜라닌 형성 세포에 독성을 보이고, 진피세포의 성장증식 효과를 보임에 따라, TNF-α의 발현을 억제시키는 효과가 저농도에서도 있으며, 0.0001%에서 억제능이 우수하게 나타났다(도 5). Experimental results show that photosynthetic microbial water fractions are toxic to keratinocytes and melanin forming cells and have a growth-proliferating effect on dermal cells. Was excellent (FIG. 5).
[실시예 3: 효능 발현을 위한 지표물질 이용 유효능 테스트(Example 3 Indicator Material Utilization Test for Efficacy Expression In vitroIn vitro )])]
광합성 미생물 내 포함된 박테리오클로로필의 양이 많지 않으므로, 어느 정도의 양이 유효한지를 알아보고자 하였다. 광합성 미생물 내 유용물질이라고 알려진 박테리오클로로필, 카로티노이드류(아스타잔틴(Astaxathin), 잔토필(Xanthophyll)), 아미노데불리닉 산(Aminolevulinic acid, ALA)을 대상으로 하여, 상기 실시예 2의 실험적 효과가 재현되는지 여부와 여타의 물질이 관여하는지를 알아보고자 했다.  Since the amount of the bacteriochlorophyll contained in the photosynthetic microorganism is not high, it was intended to find out how much is effective. Bacteriochlorophyll, carotenoids (Astaxathin, Xanthophyll), aminolevulinic acid (ALA), which are known to be useful substances in photosynthetic microorganisms, were tested. Attempts to determine whether the data is reproduced and whether other substances are involved.
실험 결과, 도 6에서 보는 바와 같이, HaCaT 세포의 독성 발현에 있어 박테리오클로로필이 가장 우수하게 나타났으며, 그외 카로티노이드 계 색소 중 잔토필 류에 해당하는 아스타잔틴이 우수하게 나타났다. 또한, 이들의 TNF-a 억제능을 실험한 결과, 도 7에서 보는 바와 같이, 아스타잔틴과 박테리오클로로필이 가장 낮은 농도에서 억제하는 것을 알 수 있었다. As shown in FIG. 6, bacteriochlorophyll was most excellent in virulence expression of HaCaT cells, and astaxanthin corresponding to xanthophylls among carotenoid pigments was excellent. In addition, as a result of experimenting with their TNF-a inhibitory ability, astaxanthin and bacteriochlorophyll were inhibited at the lowest concentration, as shown in FIG.
[실시예 4: 인공피부를 이용한 피부 효능 검증]Example 4 Skin Efficacy Verification Using Artificial Skin
피부 자극 여부는 인공피부 EPI-300 조직을 이용하여 피부 감작성 검사를 진행함으로써 평가하고자 하였다. 각 시료를 검사한 결과는 도 8과 같았다. 대조군 대비 50% 이하의 세포 생존력(cell viability)을 갖는 그룹을 자극이 있는 것으로 보았을 때, 대부분의 시료에서 큰 자극은 없는 것으로 나타났다(도 8 참조).  For skin irritation, skin sensitization test is performed using artificial skin EPI-300 tissue. To evaluate. The test results of each sample were as shown in FIG. 8. When a group with cell viability of 50% or less compared to the control group was considered to have a stimulus, there was no significant stimulus in most samples (see FIG. 8).
[실시예 5: 광합성 미생물 물 추출 분획물의 리포좀 제형에서 안정성 테스트]Example 5: Stability Test in Liposomal Formulations of Photosynthetic Microbial Water Extract Fractions
본 실시예에서는 광합성 세균 분획을 포함한 리포좀을 제조하여 안정성 여부를 확인하고자 하였다. 리포좀 제조시, 불포화도를 없애기 위해, 수첨한 정제 대두 레시친을 사용하였다. 정제 대두 레시친의 인지질 일반적인 조성은 하기 표 1과 같았다.  In this example, liposomes including photosynthetic bacterial fractions were prepared to check their stability. In preparing liposomes, hydrogenated purified soy lecithin was used to eliminate unsaturation. Phospholipid general composition of the purified soy lecithin was shown in Table 1 below.
표 1
성분 중량%
포스파티딜콜린 70-95
포스파티딜에탄올아민 0-15
포스파티딜이노시톨 0-2
리소포스파티딜콜린 0-5
Table 1
ingredient weight%
Phosphatidylcholine 70-95
Phosphatidylethanolamine 0-15
Phosphatidyl Inositol 0-2
Lysophosphatidylcholine 0-5
에 용해시켰다. 얻어진 용액으로부터 용매를 증발시키며 박막을 형성시켰다. 그 다음 지질의 상전이 온도 이상인 60℃에서 수화시키고 초음파 처리하여 일정 크기의 리포좀을 제조하였다.Dissolved in. The solvent was evaporated from the obtained solution to form a thin film. Liposomes of a certain size were then prepared by hydration and sonication at 60 ° C. above the phase transition temperature of the lipid.
40℃에서 6개월간 진행된 제형 안전성을 측정한 결과, 리포좀의 크기는 큰 변화 없이 잘 유지됨을 알 수 있었다(도 9 참조). As a result of measuring formulation safety at 40 ° C. for 6 months, it was found that the size of liposomes was well maintained without significant change (see FIG. 9).
[실시예 6: 임상시험(제형개발)] Example 6: Clinical Trial (Formulation Development)
광합성 세균 분획을 이용하여 화장품 제형을 개발하였다. 하기 표 4의 크림 베이스에 본 발명 광합성 미생물 배양 파쇄물을 10%가 되도록 첨가하여 제형을 완성하고 임상실험을 진행하였다.  Cosmetic formulations were developed using photosynthetic bacterial fractions. To the cream base of the following Table 4, the photosynthetic microbial culture lysate of the present invention was added to 10% to complete the formulation and proceed with the clinical experiment.
표 2
구분 Sysmedic cream 함량(%)
수상부 DI-Water 70.708
EDTA-2NA 0.02
Glycerine 4
1.3 -BG 2
Keltrol-F 0.05
점증제 Carbopol #940 0.1
방부제 D-M 0.2
D-P 0.1
오일부 Ⅰ Stearic acid 1
Kalcol 6870 1
Kalcol 8688 0.8
GMS 105 1
Ari 165 0.3
Mango butter 0.3
Myrj 52s 1.2
PhytoSqualane 2
CIO 3
Jojoba oil 3
LP 70 2
DC 200 / 100cs 0.5
Phytoshpningosine 0.15
Cholestrol 0.5
PC 95 0.05
오일부 Ⅱ Borage seed oil 0.3
DC345 2
추출물 Gemall 115 0.2
Vitamin E Acetate 0.5
Allantoin 0.1
DL-Panthenol 0.2
Chamomile Ext. 1
Licolice BG 100 0.2
SC-Glucan 1
Niacinamide 0.001
Guava Ext. 0.001
KXDUW0028(향) 0.18
pH 조절제 TEA 0.14
점증제 Rheocare ATH 0.2
비고 HM : Homo Mixer / PM : Paddle Mixer
-작업공정-1. 수상부를 차례로 넣은 후 80 ~ 85℃까지 투명하게 가열해 준다. 그 후 점증제를 첨가한다.2. 오일부에 방부제 및 오일부 Ⅰ과 추출물, 크림 base를 순차적으로 넣은 후 85 ~ 90℃ 까지 가열한다. 3. 오일부 I이 완전히 녹는 것을 확인 후 80℃ 정도에서 오일부 Ⅱ를 첨가한다.* Borage oil은 변질 우려가 있음으로 유화 직전에 투입하며, 900 ~ 1,000rpm(PM)으로 오일상이 완전히 녹을 때까지 혼합한다.4. 오일부 내용물이 완전히 녹은 것을 확인 후 75 ~ 80℃에서 수상부에 첨가하여 1차 유화를 하고, 4,000 ~ 4,500rpm (HM)으로 3분간 균질화 한다.5. 55℃에서 추출물과 향을 첨가하고, 3,500 ~ 4,000rpm(HM)으로 5분간 균질화 한다.6. pH 조절제를 45 ~ 50℃에서 첨가한 후 3,500 ~ 4,000rpm(HM)으로 3분간 균질화 한다.
TABLE 2
division Sysmedic cream content(%)
Award DI-Water 70.708
EDTA-2NA 0.02
Glycerin 4
1.3-BG 2
Keltrol-F 0.05
Thickener Carbopol # 940 0.1
antiseptic DM 0.2
DP 0.1
Oil part Ⅰ Stearic acid One
Kalcol 6870 One
Kalcol 8688 0.8
GMS 105 One
Ari 165 0.3
Mango butter 0.3
Myrj 52s 1.2
PhytoSqualane 2
CIO 3
Jojoba oil 3
LP 70 2
DC 200 / 100cs 0.5
Phytoshpningosine 0.15
Cholestrol 0.5
PC 95 0.05
Oil part Ⅱ Borage seed oil 0.3
DC345 2
extract Gemall 115 0.2
Vitamin E Acetate 0.5
Allantoin 0.1
DL-Panthenol 0.2
Chamomile Ext. One
Licolice BG 100 0.2
SC-Glucan One
Niacinamide 0.001
Guava Ext. 0.001
KXDUW0028 (incense) 0.18
pH regulator TEA 0.14
Thickener Rheocare ATH 0.2
Remarks HM: Homo Mixer / PM: Paddle Mixer
-Working process- 1. Put the water part in order and heat it to 80 ~ 85 ℃ transparently. Then add a thickener. 2. Put the preservative, oil part I, extract, and cream base sequentially in the oil part and heat it to 85 ~ 90 ℃. 3. After confirming that oil part I is completely dissolved, add oil part Ⅱ at about 80 ℃. * Borage oil is added just before emulsification because there is a risk of deterioration. Mix until 4. After confirming that the oil content is completely dissolved, it is added to the water phase at 75 to 80 ° C. to give the first emulsification, and homogenize at 4,000 to 4,500 rpm (HM) for 3 minutes. Add extract and flavor at 55 ° C and homogenize for 5 min at 3,500-4,000 rpm (HM). After adding the pH adjuster at 45 ~ 50 ℃ homogenization for 3 minutes at 3,500 ~ 4,000rpm (HM).
상기에서 제조한 광합성 미생물 분획물 제품의 시험군과 이를 제외한 대조군을 PNK(피엔케이) 피부임상연구센터에 의뢰하여 “피부건조증에 의한 가려움증 완화에 대한 인체효능평가”를 표준시험방법(SOP)에 따라 진행하였다. The test group of the photosynthetic microbial fraction product prepared above and the control group other than the control group were commissioned to the PNK (P & K) Skin Clinical Research Center, and the "human efficacy evaluation for alleviation of itching caused by dry skin" was conducted according to the standard test method (SOP). It was.
임상시험에는 ① 피부수분함유량, ② 경표피수분증발량, ③ 피부온도측정, ④ 피부 pH 측정, ⑤ SCORAD index 변화율의 5가지 항목을 측정하였으며, 아래와 같은 피험자를 대상으로 진행하였다. In clinical trials, five items were measured: ① skin moisture content, ② epidermal moisture evaporation, ③ skin temperature measurement, ④ skin pH measurement, and ⑤ SCORAD index change rate.
표 3
만 연령(세) 인원수(명) %
1 ~ 9 22 47.8
10 ~ 19 9 19.6
20 ~ 29 10 21.7
30 ~ 39 5 10.9
TABLE 3
Age (years) Number of people %
1 to 9 22 47.8
10 to 19 9 19.6
20 to 29 10 21.7
30 to 39 5 10.9
임상시험 제품 사용에 대한 순응도는 시험기간 동안 사용해야 할 횟수에 대한 사용한 횟수의 백분율로 구하였다. 시험을 종료한 43명의 전체 순응도는 95.7%로, 최대 순응도는 100%, 최저 순응도는 81.5% 였다. 본 임상시험에서는 80% 미만의 순응도를 보인 피험자가 없었기 때문에 43명 모두의 피험자 데이터를 결과 분석에 사용하였다. 본 임상시험에 참여한 46명 중 3명이 추적실패로 탈락하여 총 43명이 시험을 종료하였으며, 중도 탈락자 정보는 아래와 같았다(표 4).  Compliance with clinical product use was calculated as a percentage of the number of uses used over the course of the trial. The total compliance of the 43 who completed the test was 95.7%, with a maximum compliance of 100% and a minimum compliance of 81.5%. Since no subjects showed less than 80% compliance in this trial, all 43 subject data were used for outcome analysis. Three of the 46 patients who participated in this trial were eliminated due to follow-up failure, and a total of 43 completed the trial. The dropout information was as follows (Table 4).
표 4
탈락자 12N14-A1-14 12N14-A1-18 12N14-A1-46
탈락사유 추적실패 추적실패 추적실패
탈락일 D28 D14 D14
성별
연령 22 20 7
Table 4
Dropout 12N14-A1-14 12N14-A1-18 12N14-A1-46
Reason for dropping out Tracking failure Tracking failure Tracking failure
Dropout date D28 D14 D14
gender female male male
age 22 20 7
광합성 미생물 분획물 10% 함유 크림 베이스 제품과 광합성 미생물 분획물이 첨가되지 않은 크림 베이스 제품을 대상으로 진행된 임상시험 결과는 도 10 내지 14와 같았다. 피부 수분 함유량의 경우, 대조제품의 변화율과 비교하여 사용 2주 후 15.25%, 사용 4주 후 28.26% 더 증가하는 것으로 나타났다. 경표피 수분 증발량의 경우, 대조제품의 개선율과 비교할 때, 사용 2주 후 9.42%, 사용 4주 후 16.59% 더 증가하는 것으로 나타났다. 피부 온도 변화율의 경우, 대조제품의 개선율과 비교할 때, 사용 2주 후 0.14%, 사용 4주 후 0.57% 더 증가하는 것으로 나타났다. SCORAD index의 경우, 대조제품의 변화율과 비교할 때, 사용 2주 후 1.39%, 사용 4주 후 0.07% 더 증가하는 것으로 나타났다. The clinical trial results of the cream base product containing 10% photosynthetic microbial fraction and the cream base product to which the photosynthetic microbial fraction was not added were as shown in FIGS. 10 to 14. The skin moisture content was increased by 15.25% after 2 weeks and 28.26% after 4 weeks of use compared to the change rate of the control product. As for the epidermal moisture evaporation rate, it was found to increase 9.42% after 2 weeks and 16.59% after 4 weeks of use, compared to the improvement rate of the control product. The change in skin temperature was found to increase 0.14% after two weeks of use and 0.57% after four weeks of use, compared to the rate of improvement of the control product. The SCORAD index increased by 1.39% after 2 weeks of use and 0.07% after 4 weeks of use, compared to the rate of change of the control product.
결과적으로 광합성 미생물이 함유된 크림 베이스 제품이 광합성 미생물이 함유되지 않은 제품에 비해 전체적으로 피부건조증이 개선됨을 알 수 있었다. 이때, 대조 제품과의 차이가 크지 않음은 크림 베이스의 제형이 본래 피부 개선에 어느 정도 효과가 있음으로 기인하는 현상이다.  As a result, it was found that the cream base product containing photosynthetic microorganisms improved skin dryness as compared to the product containing no photosynthetic microorganisms. At this time, the difference with the control product is not a large phenomenon due to the fact that the cream base formulation has some effect on skin improvement.
[규칙 제91조에 의한 정정 14.03.2013] 
Figure WO-DOC-100
[Correction under Rule 91 14.03.2013]
Figure WO-DOC-100

Claims (4)

  1. 박테리오클로로필(bacteriochlorophyll)을 함유하는 로도박터 스패로이드데스(Rhodobacter sphaeroides)를 배양하는 단계;Culturing Rhodobacter sphaeroides containing bacteriochlorophyll;
    상기 배양 후, 배양액을 제거하고 균체를 회수하는 단계; After the incubation, removing the culture solution and recovering the cells;
    상기에서 회수한 균체를 파쇄하는 단계; Crushing the recovered cells;
    상기 균체 파쇄 후, 추출 용매를 가하고 원심분리하는 단계; After crushing the cells, adding an extraction solvent and centrifuging;
    상기 원심분리 후, 상등액을 회수하는 단계;를 포함하는 과정으로부터 제조된 박테리오클로로필 함유 추출액을 유효성분으로 포함하는 것을 특징으로 하는 피부 자극 완화용 화장료 조성물.  After the centrifugation, recovering the supernatant; a cosmetic composition for alleviating skin irritation, comprising a bacteriochlorophyll-containing extract prepared from the process comprising as an active ingredient.
  2. 박테리오클로로필(bacteriochlorophyll)을 함유하는 로도박터 스패로이드데스(Rhodobacter sphaeroides)를 배양하는 단계;Culturing Rhodobacter sphaeroides containing bacteriochlorophyll;
    상기 배양 후, 배양액을 제거하고 균체를 회수하는 단계; After the incubation, removing the culture solution and recovering the cells;
    상기에서 회수한 균체를 파쇄하는 단계; Crushing the recovered cells;
    상기 균체 파쇄 후, 추출 용매를 가하고 원심분리하는 단계; After crushing the cells, adding an extraction solvent and centrifuging;
    상기 원심분리 후, 상등액을 회수하는 단계;를 포함하는 과정으로부터 제조된 박테리오클로로필 함유 추출액을 유효성분으로 포함하는 것을 특징으로 하는 피부 보습용 화장료 조성물.  After the centrifugation, recovering the supernatant; moisturizing cosmetic composition comprising a bacteriochlorophyll-containing extract prepared from the process comprising as an active ingredient.
  3. 제1항 또는 제2항에 있어서, The method according to claim 1 or 2,
    상기 균체의 파쇄는, Crushing the cells,
    균체에 초음파를 가하여 수행하는 것을 특징으로 하는 화장료 조성물.  Cosmetic composition, characterized in that performed by applying ultrasonic waves to the cells.
  4. 제1항 또는 제2항에 있어서, The method according to claim 1 or 2,
    상기 용매는, The solvent,
    물, 에탄올 수용액, 메탄올 수용액, 에틸 아세테이트, 클로로포름 및 헥산 중 선택되는 어느 하나 또는 이들을 혼합물인 것을 특징으로 하는 화장료 조성물.  Cosmetic composition, characterized in that any one selected from water, aqueous ethanol, aqueous methanol solution, ethyl acetate, chloroform and hexane or a mixture thereof.
PCT/KR2013/000331 2013-01-09 2013-01-16 Cosmetic composition comprising bacteriochlorophyll-containing microbial cell piece as active ingredient WO2014109426A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020130002307A KR101320045B1 (en) 2013-01-09 2013-01-09 Cosmetic composition containing bacteria lysate with bacteriochlorophyll
KR10-2013-0002307 2013-01-09

Publications (1)

Publication Number Publication Date
WO2014109426A1 true WO2014109426A1 (en) 2014-07-17

Family

ID=49638858

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/000331 WO2014109426A1 (en) 2013-01-09 2013-01-16 Cosmetic composition comprising bacteriochlorophyll-containing microbial cell piece as active ingredient

Country Status (2)

Country Link
KR (1) KR101320045B1 (en)
WO (1) WO2014109426A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102094667B1 (en) * 2018-08-23 2020-03-30 코스맥스 주식회사 Composition for anti-aging comprising Rhodobacter sphaeroides strain or culture solution of the strain

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003055240A (en) * 2001-08-16 2003-02-26 Yorihiro Toda Pharmaceutical preparation
JP2004256423A (en) * 2003-02-25 2004-09-16 Towada Karuishi Kk Cosmetic by chlorophyll
KR20070075215A (en) * 2006-01-10 2007-07-18 나광출 A cosmetics using photosynthetic bacteria and its use
KR20120028738A (en) * 2010-09-15 2012-03-23 주식회사 두산에코비즈넷 Novel strains of rhodobacter sphaeroides, methods of preparing the same and microbial fertilzer comprising the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003055240A (en) * 2001-08-16 2003-02-26 Yorihiro Toda Pharmaceutical preparation
JP2004256423A (en) * 2003-02-25 2004-09-16 Towada Karuishi Kk Cosmetic by chlorophyll
KR20070075215A (en) * 2006-01-10 2007-07-18 나광출 A cosmetics using photosynthetic bacteria and its use
KR20120028738A (en) * 2010-09-15 2012-03-23 주식회사 두산에코비즈넷 Novel strains of rhodobacter sphaeroides, methods of preparing the same and microbial fertilzer comprising the same

Also Published As

Publication number Publication date
KR101320045B1 (en) 2013-10-18

Similar Documents

Publication Publication Date Title
EP2260829B1 (en) Use of an extract from snow algae in cosmetic or dermatological formulations
JP2008044939A (en) Slimming composition for cosmetic containing extract of biomass of alga neochloris oleoabundans
KR102119825B1 (en) A cosmetic composition for maintaining the balance of microbiom in the skin comprising brown rice, grean tea and dandelion fermentation extracts and methode thereof
KR20090096256A (en) A method for producing extract of fermented fucoxanthin and Cosmetic composition containing thereof
CN106265977B (en) Peony seed extract, preparation method and application thereof, and skin external preparation comprising peony seed extract
JP6591963B2 (en) Application of Lactobacillus pentosas to cosmetics and medicines
KR20120140141A (en) Cosmetic composition comprising the fermented extracts and the extracts of the rice
WO2012117170A2 (en) Extract of winter branches of hippophae and use thereof in a cosmetic composition
KR101841118B1 (en) Composition for skin external application comprising extract of scenedesmus sp.
CN115414308B (en) Acne-removing composition, preparation method and application
WO2020054972A1 (en) Skin whitening, anti-wrinkle and antioxidant functional cosmetic composition containing mixed extract of gloiopeltis tenax, palmaria palmata and himanthalia elongata as active ingredient, and preparation method therefor
WO2014109426A1 (en) Cosmetic composition comprising bacteriochlorophyll-containing microbial cell piece as active ingredient
EP2958547B1 (en) Cosmetic use of queuine
KR20140025737A (en) Extraction method sprout fermentation extracts using acidic ionized water and cosmetic composition comprising the extracts obtained thereby
CN114502139B (en) Moringa oleifera seed extract enriched in 2, 5-diformylfuran, method for obtaining same and use thereof in cosmetic compositions
KR20060025630A (en) Cosmetic composition for skin improvement including sprout extract
KR20190068389A (en) A cosmetic composition comprising cabbage cultiva rfermented extract
KR20220120948A (en) Cosmetic composition for improving melasma, freckles, whitenings and wrinkle comprising extract of fermented chestnut inner shell, angelica dahurica, portulace oleracea, armeniacae and mori dadicis cortex and preparation method thereof
EP3496701A1 (en) Methods and compositions for reducing the graying of hair
KR101214344B1 (en) Cosmetics composition containing fermented rice bran and licorice extract
WO2018052152A1 (en) Antiaging composition for external preparation for skin, containing extract of germinated glycine gracilis as active ingredient
EP2512495B1 (en) Process for obtaining a standardised extract of quercetin an 3-o-methylquercetin from flowers of macela (achyrocline satureioides), and cosmetic and pharmaceutical compositions comprising said extract
WO2022030803A1 (en) Cosmetic composition for preventing and ameliorating skin aging caused by ultraviolet light, containing persicaria senticosa(meisn.) h.gross ex nakai extract
JP7001450B2 (en) Compositions and anti-inflammatory agents
KR101917712B1 (en) Cosmetic composition comprising extract of azadirachta indica and paeonia lactiflora by ultrasonification and black yeast fermentation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13870608

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13870608

Country of ref document: EP

Kind code of ref document: A1